Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
5-Year Return on Invested Incremental Capital (5-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 5-year.
Yonghe Medical Group Co's 5-Year ROIIC % for the quarter that ended in Dec. 2025 was 34.80%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
The industry rank for Yonghe Medical Group Co's 5-Year ROIIC % or its related term are showing as below:
FRA:L97's 5-Year ROIIC % is ranked better than 85.53% of 532
companies
in the Healthcare Providers & Services industry
Industry Median: 3.22
vs FRA:L97: 34.80
Yonghe Medical Group Co (FRA:L97) 5-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Yonghe Medical Group Co 5-Year ROIIC % Related Terms
Yonghe Medical Group Co 5-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:L97 vs HCA, THC, DVA: 5-Year ROIIC % Comparison
For the Medical Care Facilities subindustry, Yonghe Medical Group Co's 5-Year ROIIC %, along with its competitors' market caps and 5-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Yonghe Medical Group Co 5-Year ROIIC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's 5-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Yonghe Medical Group Co's 5-Year ROIIC % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 5-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Yonghe Medical Group Co (FRA:L97) has a 5-Year ROIIC % of 34.80 as of Dec. 2025. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Yonghe Medical Group Co and its competitors. According to the industry distribution chart, Yonghe Medical Group Co ranks #77 out of 532 companies in the Healthcare Providers & Services industry, placing it in the top 14.5%.
Is Yonghe Medical Group Co's 5-Year ROIIC % too high?
Yonghe Medical Group Co's current 5-Year ROIIC % is 34.80. The Healthcare Providers & Services industry median 5-Year ROIIC % is 3.22. Yonghe Medical Group Co's value of 34.80 is 980.7% above this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #77 out of 532 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's 5-Year ROIIC % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #77 out of 532 companies for 5-Year ROIIC %. This places Yonghe Medical Group Co in the top 15% of its industry — outperforming the majority of peers. The industry median 5-Year ROIIC % is 3.22. Yonghe Medical Group Co's value of 34.80 is 980.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year ROIIC % for a Healthcare Providers & Services company?
The median 5-Year ROIIC % among Healthcare Providers & Services companies is 3.22, based on 532 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current 5-Year ROIIC % of 34.80 is 980.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year ROIIC % mean?
A high 5-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 5-Year ROIIC % measures the change in earnings as a percentage of change in investment over 5-year. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median 5-Year ROIIC % is 3.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current 5-Year ROIIC % is 34.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (FRA:L97) has a current 5-Year ROIIC % of 34.80. The stock's GF Value™ is €0.21, compared to a current price of €0.26 — trading 22.9% above its estimated fair value. The current 5-Year ROIIC % is 34.80 and 980.7% above the Healthcare Providers & Services industry median of 3.22. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year ROIIC % calculated?
5-Year ROIIC % is calculated from a company's financial statements. For Yonghe Medical Group Co (FRA:L97), the current 5-Year ROIIC % is 34.80 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Yonghe Medical Group Co (FRA:L97) Overvalued in 2026?
Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued.
The current stock price of €0.26 is trading 22.9% above its estimated GF Value™ of €0.21.
Key valuation signals for FRA:L97:
5-Year ROIIC %: 34.80
GF Value™: €0.21 vs. price of €0.26 (22.9% above fair value)
Industry Position: 980.7% above the Healthcare Providers & Services median (#77 of 532)
No single metric tells the full story. See the FRA:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score
Get the complete analysis for FRA:L97
5-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:L97 has been successfully added to your 
